Health
Novel targeted therapy blocks metabolic pathways in cancer cells with specific genetic defects – News-Medical.Net
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways…
Reviewed by Emily Henderson, B.Sc.Nov 23 2020
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects. Preclinical studies found the small-molecule enolase inhibitor to be effective in killing brain cancer cells that were missing ENO1, one of two genes encoding the enolase enzyme.
The study results, published today in Nature Metabolism, provide proof…
-
Noosa News24 hours agoMan dies after stabbing in inner-city unit
-
General23 hours agoTwo British MPs refused entry into Israel, UK foreign ministry says
-
Noosa News22 hours agoBrisbane man, 39, dies after stabbing at inner city home in early morning attack, prompting investigation
-
Business7 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?